Terry Mark A, Wall Jennifer M, Hoar Karen L, Ousley Paula J
Devers Eye Institute, Portland, Oregon 97210, USA.
Ophthalmology. 2007 Apr;114(4):631-9. doi: 10.1016/j.ophtha.2006.11.024.
To report the endothelial survival over a 2-year period after 2 techniques of deep lamellar endothelial keratoplasty (DLEK) in the treatment of endothelial dysfunction.
Prospective, noncomparative, interventional case series.
One hundred eyes of 88 patients with corneal edema.
One hundred consecutive eyes with endothelial failure were entered into a prospective study of endothelial keratoplasty, and the donor central endothelial cell density (ECD) was recorded postoperatively at 6 months (n = 98), 12 months (n = 96), and 24 months (n = 85) and then compared with the preoperative eye bank measurements. The subsets of eyes with large-incision DLEK (n = 36) and small-incision DLEK (n = 62) were also evaluated and compared.
Preoperative and postoperative central ECDs were prospectively evaluated and the cell loss calculated for each postoperative time point.
The average (and standard deviation) ECD at 6 months was 2140+/-426 cells/mm(2), representing a mean cell loss from preoperative donor cell measurements of 25+/-15%. At 12 months, ECD was 2090+/-448 cells/mm2 (26+/-16% cell loss), and at 24 months, it was 1794+/-588 cells/mm2 (37+/-27% cell loss). The additional cell loss from 1 to 2 years was significant (P<0.001). In the subset of large-incision DLEK eyes (n = 36), the cell loss from preoperatively to 6 months was 23%; 12 months, 22%; and 24 months, 27%. In the subset of small-incision DLEK eyes (n = 62), the cell loss from preoperatively to 6 months was 25%; 12 months, 28%; and 24 months, 43%. The cell loss from small-incision DLEK surgery was significantly greater than that from large-incision DLEK surgery at the 12-month (P = 0.013) and 24-month (P<0.001) postoperative measurements.
Although the initial cell loss from DLEK surgery is minimally changed from 6 to 12 months postoperatively, there is an acceleration of cell loss from 1 year to 2 years postoperatively. The small-incision DLEK technique, which involves folding of the donor tissue, results in a significantly higher endothelial cell loss at 1 and 2 years than that found after large-incision DLEK surgery, wherein the tissue is not folded.
报告两种深板层内皮角膜移植术(DLEK)治疗内皮功能障碍后2年内的内皮细胞存活情况。
前瞻性、非对照、干预性病例系列研究。
88例角膜水肿患者的100只眼。
100只连续的内皮功能衰竭眼纳入内皮角膜移植术的前瞻性研究,术后6个月(n = 98)、12个月(n = 96)和24个月(n = 85)记录供体中央内皮细胞密度(ECD),然后与术前眼库测量值进行比较。还对大切口DLEK组(n = 36)和小切口DLEK组(n = 62)的眼进行评估和比较。
前瞻性评估术前和术后中央ECD,并计算每个术后时间点的细胞丢失率。
6个月时平均(及标准差)ECD为2140±426个细胞/mm²,相对于术前供体细胞测量值,平均细胞丢失率为25±15%。12个月时,ECD为2090±448个细胞/mm²(细胞丢失率为26±16%),24个月时为1794±588个细胞/mm²(细胞丢失率为37±27%)。术后1至2年的额外细胞丢失显著(P<0.001)。在大切口DLEK组(n = 36)中,术前至6个月的细胞丢失率为23%;12个月时为22%;24个月时为27%。在小切口DLEK组(n = 62)中,术前至6个月的细胞丢失率为25%;12个月时为28%;24个月时为43%。术后12个月(P = 0.013)和24个月(P<0.001)测量时,小切口DLEK手术的细胞丢失率显著高于大切口DLEK手术。
虽然DLEK手术后最初6至12个月的细胞丢失变化最小,但术后1至2年细胞丢失加速。小切口DLEK技术涉及供体组织折叠,导致术后1年和2年的内皮细胞丢失率显著高于大切口DLEK手术,后者组织不折叠。